Apolipoprotein A5 gene polymorphism (rs662799) and cardiovascular disease in end-stage kidney disease patients

Apolipoprotein A5 gene polymorphism (rs662799) and cardiovascular disease in end-stage kidney disease patients

Abstract Background Plasma triglyceride (TG) levels are a significant risk factor for cardiovascular disease (CVD). The APOA5 gene is one of the crucial factors in plasma TG metabolism regulation. The rs662799 polymorphism in the APOA5 gene has been reported to be associated with cardiovascular dise...

Full description

Bibliographic Details
Main Authors: Jerry Jacob, Sylwia Boczkowska, Wojciech Zaluska, Monika Buraczynska
Format: Article
Language:English
Published: BMC 2022-09-01
Series:BMC Nephrology
Subjects:
Apolipoprotein A5
End-stage kidney disease
rs662799 polymorphism
Genotyping
Risk allele
Triglycerides
Online Access:https://doi.org/10.1186/s12882-022-02925-1

Internet

https://doi.org/10.1186/s12882-022-02925-1

Similar Items